Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

Arch Gen Psychiatry. 1993 Jun;50(6):448-55. doi: 10.1001/archpsyc.1993.01820180046005.

Abstract

Objective: Withdrawal of bipolar mood disorder (BP-I) patients from prolonged, stable lithium maintenance has a high risk of early recurrence, particularly of mania. We thus compared risks of stopping lithium rapidly vs gradually.

Design: Outpatients undergoing clinically determined discontinuation of lithium treatment at different rates were followed up prospectively to 5 years. Risks and timing of new episodes were analyzed.

Patients: Subjects (N = 64) with a DSM-III-R BP disorder, previously stable on lithium monotherapy for 18 to 120 months (mean, 3.6 years) were followed up clinically after discontinuing lithium (elected in prolonged wellbeing in 67%). None was unavailable for follow-up, and subtyping (BP-I or BP-II) remained stable.

Results: Within 5 years, 75% had a recurrent episode; BP-I patients were 1.5-times less likely than BP-II to remain in remission. Polarity of first-recurrent and onset episodes was 80.8% concordant. Overall risk of a new episode of mania was significantly greater after rapid (< 2) than gradual (2 to 4 weeks discontinuation (5-year hazard ratio = 2.8); the difference in risk of depression was even greater hazard ratio = 5.4). Recurrence rate was more elevated within months of rapid discontinuation (12-month hazard ratio = 5.4). Recurrence rate was more elevated within months of rapid discontinuation (12-month hazard ratio = 4.3) than at later times (2 to 5 years), when courses of "survival" over time were nearly parallel in both discontinuation groups.

Conclusions: Risk of early recurrence of BP disorder following discontinuation of lithium maintenance is elevated, but may be both predictable (timing and polarity) and modifiable by gradual discontinuation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Ambulatory Care
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / prevention & control
  • Bipolar Disorder / psychology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / prevention & control
  • Depressive Disorder / psychology
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Lithium Carbonate / administration & dosage*
  • Male
  • Middle Aged
  • Probability
  • Prospective Studies
  • Recurrence
  • Substance Withdrawal Syndrome / etiology
  • Substance Withdrawal Syndrome / prevention & control
  • Survival Analysis
  • Treatment Outcome

Substances

  • Lithium Carbonate